- Home
- DYN vs ATEC Comparison
DYN vs ATEC Comparison
Compare DYN & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | ATEC |
|---|---|---|
| Founded | 1984 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | DYN | ATEC |
|---|---|---|
| Price | $17.42 | $17.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $39.94 | $22.36 |
| AVG Volume (30 Days) | 1.9M | ★ 3.5M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $728,020,000.00 |
| Revenue This Year | N/A | $26.81 |
| Revenue Next Year | N/A | $16.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 27.11 |
| 52 Week Low | $6.36 | $8.81 |
| 52 Week High | $25.00 | $23.29 |
Technical Indicators
Market Signals| Indicator | DYN | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 36.78 |
| Support Level | $16.00 | $15.42 |
| Resistance Level | $17.50 | $17.97 |
| Average True Range (ATR) | 1.02 | 1.16 |
| MACD | -0.14 | -0.45 |
| Stochastic Oscillator | 38.59 | 21.22 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About ATEC Alphatec Holdings Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.